Multi-Cohort Transcriptomic Subtyping of B-Cell Acute Lymphoblastic Leukemia

Files

hdl_135208.pdf (988.4 KB)
  (Published version)

Date

2022

Authors

Mäkinen, V.-P.
Rehn, J.
Breen, J.
Yeung, D.
White, D.L.

Editors

Advisors

Journal Title

Journal ISSN

Volume Title

Type:

Journal article

Citation

International Journal of Molecular Sciences, 2022; 23(9):1-17

Statement of Responsibility

Ville-Petteri Mäkinen, Jacqueline Rehn, James Breen, David Yeung, and Deborah L. White

Conference Name

Abstract

RNA sequencing provides a snapshot of the functional consequences of genomic lesions that drive acute lymphoblastic leukemia (ALL). The aims of this study were to elucidate diagnostic associations (via machine learning) between mRNA-seq profiles, independently verify ALL lesions and develop easy-to-interpret transcriptome-wide biomarkers for ALL subtyping in the clinical setting. A training dataset of 1279 ALL patients from six North American cohorts was used for developing machine learning models. Results were validated in 767 patients from Australia with a quality control dataset across 31 tissues from 1160 non-ALL donors. A novel batch correction method was introduced and applied to adjust for cohort differences. Out of 18,503 genes with usable expression, 11,830 (64%) were confounded by cohort effects and excluded. Six ALL subtypes (ETV6::RUNX1, KMT2A, DUX4, PAX5 P80R, TCF3::PBX1, ZNF384) that covered 32% of patients were robustly detected by mRNA-seq (positive predictive value ≥ 87%). Five other frequent subtypes (CRLF2, hypodiploid, hyperdiploid, PAX5 alterations and Ph-positive) were distinguishable in 40% of patients at lower accuracy (52% ≤ positive predictive value ≤ 73%). Based on these findings, we introduce the Allspice R package to predict ALL subtypes and driver genes from unadjusted mRNA-seq read counts as encountered in real-world settings. Two examples of Allspice applied to previously unseen ALL patient samples with atypical lesions are included.

School/Discipline

Dissertation Note

Provenance

Description

Access Status

Rights

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).

License

Call number

Persistent link to this record